Trials / Recruiting
RecruitingNCT03299179
The Effects of the Female Hormones on Cerebral Perfusion
The Effects of the Female Sex Hormones and Hormonal Contraception on Cerebral Perfusion
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 62 (estimated)
- Sponsor
- University Ghent · Academic / Other
- Sex
- Female
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Accepted
Summary
Measuring brain perfusion is biased by a inter- and intrasubject variability, caused by physiological and lifestyle factors. In this study, the investigators want to investigate the variations in cerebral perfusion and other brain parameters (grey matter, resting-state brain activity, brain connectivity and white matter diffusion) caused by the female sex hormones and hormonal contraception.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MRI scan | Several MRI scan modalities: MPRAGE (structural scan), arterial spin labeling (cerebral perfusion), resting state functional-MRI (fMRI, cerebral activity) and diffusion MRI (white matter diffusion and white matter tracts). |
| DEVICE | Physiological monitoring | During MRI: heart rate, end-tidal carbon dioxide (CO2), respiratory rate and skin conductance |
| BIOLOGICAL | Blood sample | Blood sample after MRI-session: measurement of hematocrit, hemoglobin, estradiol, progesterone, follicle stimulation hormone and luteinizing hormone. |
| DEVICE | Blood pressure measurement | Measuring blood pressure before and after MRI-scan |
| DEVICE | Body temperature | Measuring body temperature before and after MRI-scan |
| OTHER | Questionnaires | Questionnaires at the start of the study on lifestyle. Additionally, a questionnaire before each scan session on the actual state of the volunteer (e.g. mood, caffeine consumption, alcohol, medication, etc.) |
| DIAGNOSTIC_TEST | Pregnancy test | Test for pregnancy using a pregnancy dipstick test |
Timeline
- Start date
- 2016-10-03
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2017-10-02
- Last updated
- 2023-12-06
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03299179. Inclusion in this directory is not an endorsement.